HRSA is requesting nominations for voting members to serve on the Advisory Commission on Childhood Vaccines (ACCV). Read the Federal Register notice (PDF - 174 KB).
The ACCV consists of nine voting members appointed by the Secretary. HRSA is requesting nominations for voting members of the ACCV representing: (1) Three health professionals, who are not employees of the United States Government, and who have expertise in the health care of children, the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines, of whom at least two shall be pediatricians; (2) three members from the general public, of whom at least two shall be legal representatives (parents or guardians) of children who have suffered a vaccine-related injury or death; and (3) three attorneys, of whom at least one shall be an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death, and of whom one shall be an attorney whose specialty includes representation of vaccine manufacturers. Based on a recommendation made by the ACCV, the Secretary will consider having a health professional with expertise in obstetrics as the second member of the general public. Nominees will be invited to serve a 3‑year term beginning the date of appointment.
Specifically HRSA is seeking a member from the general public who is the legal representative (parent or guardian) of a child who has suffered a vaccine-related injury or death. To be considered for appointment to the ACCV in this category there must have been a finding (i.e., a decision) by the U.S. Court of Federal Claims or a civil court that a VICP-covered vaccine caused, or was presumed to have caused, the represented child’s injury or death.
ACCV members are appointed as Special Government Employees. As such, they are covered by the federal ethics rules, including the criminal conflict of interest statutes governing executive branch employees. For example, an ACCV member may be prohibited from discussions about making changes to the Vaccine Injury Table and Vaccine Information Statements for the Hepatitis B vaccine if he/she or his/her spouse owns stock valued above a certain amount in companies which manufacturer this vaccine, affecting their own pecuniary interests - including interests imputed to them. To evaluate possible conflicts of interest, potential candidates will be asked to fill out the Confidential Financial Disclosure Report, OGE Form 450, to provide detailed information concerning financial interests, consultancies, research grants, and/or contracts that might be affected by recommendations made by the ACCV.
All nominations are to be submitted to the address below:
Director, Division of Injury Compensation Programs
Healthcare Systems Bureau
Health Resources and Services Administration
5600 Fishers Lane
Rockville, MD 20857
For further information contact Ms. Annie Herzog, Principal Staff Liaison at 301-443-6634 or email firstname.lastname@example.org.
Last Reviewed: March 2017